169 related articles for article (PubMed ID: 28647425)
41. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.
Brown K; Valenta K; Fisman D; Simor A; Daneman N
JAMA Intern Med; 2015 Apr; 175(4):626-33. PubMed ID: 25705994
[TBL] [Abstract][Full Text] [Related]
42. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.
Kyne L; Sougioultzis S; McFarland LV; Kelly CP
Infect Control Hosp Epidemiol; 2002 Nov; 23(11):653-9. PubMed ID: 12452292
[TBL] [Abstract][Full Text] [Related]
43. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.
Tariq R; Pardi DS; Tosh PK; Walker RC; Razonable RR; Khanna S
Clin Infect Dis; 2017 Oct; 65(10):1745-1747. PubMed ID: 29020210
[TBL] [Abstract][Full Text] [Related]
44. A study into the effect of
Wong S; Hirani SP; Forbes A; Kumar N; Hariharan R; O'Driscoll J; Viswanathan A; Harvey G; Sekhar R; Jamous A
EClinicalMedicine; 2021 Oct; 40():101098. PubMed ID: 34541475
[TBL] [Abstract][Full Text] [Related]
45. Clostridium difficile infection: a Serbian single-center experience.
Korac M; Milosevic I; Markovic M; Popovic N; Ilic M; Markovic A; Nikolic J; Jevtovic D
J Infect Dev Ctries; 2015 Feb; 9(2):136-40. PubMed ID: 25699487
[TBL] [Abstract][Full Text] [Related]
46. Clostridium difficile postantibiotic diarrhoea diagnosis.
Haider Naqvi SA; Chaudhry FF
J Coll Physicians Surg Pak; 2012 Oct; 22(10):640-3. PubMed ID: 23058147
[TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
Asha NJ; Tompkins D; Wilcox MH
J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
[TBL] [Abstract][Full Text] [Related]
48. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
49. Do probiotics prevent antibiotic-associated diarrhoea? Results of a multicentre randomized placebo-controlled trial.
Rajkumar C; Wilks M; Islam J; Ali K; Raftery J; Davies KA; Timeyin J; Cheek E; Cohen J;
J Hosp Infect; 2020 Jun; 105(2):280-288. PubMed ID: 32035998
[TBL] [Abstract][Full Text] [Related]
50. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
[TBL] [Abstract][Full Text] [Related]
51. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
[TBL] [Abstract][Full Text] [Related]
52. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
[TBL] [Abstract][Full Text] [Related]
53. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of Clostridium perfringens toxin in patients suspected of having antibiotic-associated diarrhea.
Kim YJ; Kim SH; Ahn J; Cho S; Kim D; Kim K; Lee H; Son H; Lee HJ; Yong D; Choi JY; Kim HR; Shin JH
Anaerobe; 2017 Dec; 48():34-36. PubMed ID: 28655582
[TBL] [Abstract][Full Text] [Related]
55. Community-acquired Clostridium difficile infection in children: A retrospective study.
Borali E; Ortisi G; Moretti C; Stacul EF; Lipreri R; Gesu GP; De Giacomo C
Dig Liver Dis; 2015 Oct; 47(10):842-6. PubMed ID: 26141927
[TBL] [Abstract][Full Text] [Related]
56. Economic evaluation of S. boulardii CNCM I-745 for prevention of antibioticassociated diarrhoea in hospitalized patients.
Vermeersch SJ; Vandenplas Y; Tanghe A; Elseviers M; Annemans L
Acta Gastroenterol Belg; 2018; 81(2):269-276. PubMed ID: 30024698
[TBL] [Abstract][Full Text] [Related]
57. High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.
Komatsu M; Kato H; Aihara M; Shimakawa K; Iwasaki M; Nagasaka Y; Fukuda S; Matsuo S; Arakawa Y; Watanabe M; Iwatani Y
Eur J Clin Microbiol Infect Dis; 2003 Sep; 22(9):525-9. PubMed ID: 12938013
[TBL] [Abstract][Full Text] [Related]
58. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
[TBL] [Abstract][Full Text] [Related]
59. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections.
Shan LS; Hou P; Wang ZJ; Liu FR; Chen N; Shu LH; Zhang H; Han XH; Han XX; Cai XX; Shang YX; Vandenplas Y
Benef Microbes; 2013 Dec; 4(4):329-334. PubMed ID: 24311316
[TBL] [Abstract][Full Text] [Related]
60. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
